The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway
Open accessAbstract
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that is able to persist for decades in its host. HCMV has evolved protean countermeasures for anti-HCMV cellular immunity that facilitate establishment of persistence. Recently it has been shown that HCMV inhibits interferon γ (IFN-γ)–stimulated MHC class II expression, but the mechanism for this effect is unknown. IFN-γ signal transduction (Jak/Stat pathway) and class II transactivator (CIITA) are required components for IFN-γ–stimulated MHC class II expression. In this study, we demonstrate that both a clinical isolate and a laboratory strain of HCMV inhibit inducible MHC class II expression at the cell surface and at RNA level in human endothelial cells and fibroblasts. Moreover, reverse transcriptase polymerase chain reaction and Northern blot analyses demonstrate that neither CIITA nor interferon regulatory factor 1 are upregulated in infected cells. Electrophoretic mobility shift assays reveal a defect in IFN-γ signal transduction, which was shown by immunoprecipitation to be associated with a striking decrease in Janus kinase 1 (Jak1) levels. Proteasome inhibitor studies with carboxybenzyl-leucyl-leucyl-leucine vinyl sulfone suggest an HCMV-associated enhancement of Jak1 protein degradation. This is the first report of a mechanism for the HCMV-mediated disruption of inducible MHC class II expression and a direct virus-associated alteration in Janus kinase levels. These findings are yet another example of the diverse mechanisms by which HCMV avoids immunosurveillance and establishes persistence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Wiertz, E. J. H. J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T. R., Rapoport, T. A., & Ploegh, H. L. (1996) · Nature · doi:10.1038/384432a0 · Cited by 1,105
Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J., & Ploegh, H. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81054-5 · Cited by 1,072
Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B. (1994) · Science · doi:10.1126/science.8016643 · Cited by 898 · cited 1×
“CIITA, an IFNg–induced transcription factor, is required for activation of MHC class II promoters and transcription of class II genes (16).”
The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction
Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., et al. (1993) · Nature · doi:10.1038/366129a0 · Cited by 760
Signaling Through the Hematopoietic Cytokine Receptors
Ihle, J. N. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.369 · Cited by 612
Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Rogers, N. C., Schindler, C., Stark, G. R., Ihle, J. N., et al. (1993) · Nature · doi:10.1038/366166a0 · Cited by 533
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
Ahn, K., Gruhler, A., Galocha, B., Jones, T. R., Wiertz, E. J. H. J., Ploegh, H. L., Peterson, P. A., Yang, Y., & Früh, K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80349-0 · Cited by 477 · cited 1×
“processing (54), and encode an MHC class I homologue (3, 4).”
Orange, J. S., Wang, B., Terhorst, C., & Biron, C. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1045 · Cited by 455
Bogyo, M., McMaster, J. S., Gaczynska, M., Tortorella, D., Goldberg, A. L., & Ploegh, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6629 · Cited by 447
Jones, T. R., Wiertz, E. J., Sun, L., Fish, K. N., Nelson, J. A., & Ploegh, H. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11327 · Cited by 414
Widespread presence of histologically occult cytomegalovirus
Myerson, D., Hackman, R. C., Nelson, J. A., Ward, D. C., & McDougall, J. K. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80076-3 · Cited by 399
Sinzger, C., Grefte, A., Plachter, B., Gouw, A. S. H., The, T. H., & Jahn, G. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-4-741 · Cited by 389
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
Ahn, K., Angulo, A., Ghazal, P., Peterson, P. A., Yang, Y., & Früh, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10990 · Cited by 378
Structural analysis of the major immediate early gene of human cytomegalovirus
Stenberg, R. M., Thomsen, D. R., & Stinski, M. F. (1984) · Journal of Virology · doi:10.1128/jvi.49.1.190-199.1984 · Cited by 337
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells
Reyburn, H. T., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Pazmany, L., & Strominger, J. L. (1997) · Nature · doi:10.1038/386514a0 · Cited by 321
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo
Farrell, H. E., Vally, H., Lynch, D. M., Fleming, P., Shellam, G. R., Scalzo, A. A., & Davis-Poynter, N. J. (1997) · Nature · doi:10.1038/386510a0 · Cited by 306
Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands
Lucin, P., Pavić, I., Polić, B., Jonjić, S., & Koszinowski, U. H. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.1977-1984.1992 · Cited by 245
Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes
Jonjić, S., Pavić, I., Lucin, P., Rukavina, D., & Koszinowski, U. H. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5457-5464.1990 · Cited by 202
Regulation of transcription of MHC class II genes
Boss, J. M. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80166-5 · Cited by 195
Self-citationHuman cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains
Jones, T. R., & Sun, L. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2970-2979.1997 · Cited by 165
Interaction between the Components of the Interferon γ Receptor Complex
Kotenko, S. V., Izotova, L. S., Pollack, B. P., Mariano, T. M., Donnelly, R. J., Muthukumaran, G., Cook, J. R., Garotta, G., Silvennoinen, O., Ihle, J. N., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20915 · Cited by 164
Hobart, M., Ramassar, V, Goes, N., Urmson, J., & Halloran, P. F. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4260 · Cited by 163
Percivalle, E., Revello, M. G., Vago, L., Morini, F., & Gerna, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116635 · Cited by 155
Sakatsume, M., Igarashi, K., Winestock, K. D., Garotta, G., Larner, A. C., & Finbloom, D. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17528 · Cited by 151
Human cytomegalovirus. III. Virus-induced DNA polymerase
Huang, E. S. (1975) · Journal of Virology · doi:10.1128/jvi.16.2.298-310.1975 · Cited by 150
Ligand-Induced Assembly and Activation of the Gamma Interferon Receptor in Intact Cells
Bach, E. A., Tanner, J. W., Marsters, S., Ashkenazi, A., Aguet, M., Shaw, A. S., & Schreiber, R. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.3214 · Cited by 145
Waldman, W. J., Knight, D. A., Huang, E. H., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.263 · Cited by 129
Davignon, J., Castanié, P., Yorke, J. A., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2162-2169.1996 · Cited by 110
Replication of Human Cytomegalovirus in Endothelial Cells
Ho, D. D., Rara, T. R., Andrews, C. A., et al. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/150.6.956 · Cited by 104
Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells.
Dd, S., Am, G., Da, K., et al. (1994) · PubMed · Cited by 84
Hibino, Y., Kumar, C. S., Mariano, T. M., Lai, D., & Pestka, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50588-9 · Cited by 75
Lindsley, M. D., Torpey, D. J., & Rinaldo, C. R. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.8.3045 · Cited by 67
Cytomegalovirus- and interferon-related effects on human endothelial cells
Scholz, M., Hamann, A., Blaheta, R. A., Auth, M. K. H., Encke, A., & Markus, B. H. (1992) · Human Immunology · doi:10.1016/0198-8859(92)90004-7 · Cited by 65
Jabrane‐Ferrat, N., Fontes, J. D., Boss, J. M., & Peterlin, B. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4683 · Cited by 58
Self-citationLoh, J. E., Chang, C., Fodor, W. L., & Flavell, R. A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05180.x · Cited by 55
Cytomegalovirus persistence in macrophages and endothelial cells.
Fish, K. N., Stenglein, S., Ibañez, C. E., et al. (1995) · PubMed · Cited by 50
Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5
Brown, J., He, X., Westerheide, S. D., & Boss, J. M. (1995) · Immunogenetics · doi:10.1007/bf00186611 · Cited by 29
Self-citation
Cited by
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Regulation of JAK–STAT signalling in the immune system
Shuai, K., & Liu, B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1226 · Cited by 1,372
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Metadata
- Authors
- Miller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, J. W., & Sedmak, D. D.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-03-02
- Volume
- 187
- Issue
- 5
- Pages
- 675-683
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2057272534
- Cited by
- 337
- References
- 41
- FWCI
- 29.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.